Biotechnology Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity – Cullinan Oncology (NASDAQ:CGEM) Read more
Cannabis EXCLUSIVE: Cannabis Tech Company Eyes Expansion In German Cannabis Market Amid Legal Shifts Read more
Stockmarkets Zepp Health reports record margins, shifts focus to self-branding By biedexmarkets.com Read more